허혈성 좌심실 부전증에서의 좌심실내 원형 패취성형술

Endoventricular Circular Patch Plasty (Dor Procedure) for Ischemic Left Ventricular Dysfunction

  • 조광리 (서울대학교 의과대학 흉부외과학교실) ;
  • 임청 (서울대학교 의과대학 흉부외과학교실) ;
  • 최재성 (서울대학교 의과대학 흉부외과학교실) ;
  • 홍장미 (서울대학교 의과대학 흉부외과학교실) ;
  • 김형렬 (서울대학교 의과대학 흉부외과학교실) ;
  • 김기봉 (서울대학교 의과대학 흉부외과학교실)
  • Cho, Kwang-Ree (Dept. of Thoracic and Cardiovascular Surgery, Seoul National University College Medicine) ;
  • Lim, Cheong (Dept. of Thoracic and Cardiovascular Surgery, Seoul National University College Medicine) ;
  • Choi, Jae-Sung (Dept. of Thoracic and Cardiovascular Surgery, Seoul National University College Medicine) ;
  • Hong, Jang-Mee (Dept. of Thoracic and Cardiovascular Surgery, Seoul National University College Medicine) ;
  • Kim, Hyeong-Ryul (Dept. of Thoracic and Cardiovascular Surgery, Seoul National University College Medicine) ;
  • Kim, Ki-Bong (Dept. of Thoracic and Cardiovascular Surgery, Seoul National University College Medicine)
  • 발행 : 2004.09.01

초록

말기 허혈성 심근질환에서 좌심실내 원형패취 성형술(Dor 술식)이 심근 기능의 개선에 미치는 영향을 알아보고자 서울대학교병원 흉부외과에서 시행한 Dor 술식의 결과를 분석해 보았다. 대상 및 방법: 1998년 4월부터 2002년 12월 사이에 좌심박출계수 35% 이하의 허혈성 심근질환으로 관상동맥우회술과 함께 Dor 술식을 시행한 45례의 환자를 대상으로 수술 전, 수술 직후 및 술 후 1년째에 심초음파, 심근 SPECT, 심도자 및 조영술을 시행하여 좌심실 박출계수 및 용적 등의 변화를 비교 분석하였다. 결과: 심폐바이패스 및 대동맥 차단시간은 각각 평균 141$\pm$64, 69$\pm$24분이었다. 7례에서 수술전에 대동맥내풍선펌프를 사용하였으며 수술 중 및 수술 후 저심박출 증후군을 보인 9례와 3례에서 대동맥내 풍선펌프를 삽입하였다. 수술 사망은 1례(2.2%)가 있었으며, 합병증으로는 저심박출 증후군(12례), 심방세동(5례), 급성신부전(4례), 출혈에 의한 재수술(4례) 등이 있었다. 술 후 1개월째 환자의 NYHA 기능지수는 평균 2.8에서 1.1로 유의하게 향상되었다(p < 0.01). 수술 직후 시행한 좌심실조영술상 박출계수는 수술 전과 비교해서 32 $\pm$ 9%에서 52$\pm$11%로, asynergy 분획은 57 $\pm$ 12%에서 22 $\pm$ 9%로, 좌심실확장기말, 수축기말 용적 계수들도 각각 125$\pm$39 mL/$m^2$, 85 $\pm$30 mL/$m^2$에서 66$\pm$23 mL/$m^2$, 32$\pm$16 mL/$m^2$으로 통계적으로 유의한 개선을 보였다(p<0.01). 술 후 1년째에 시행한 심초음파검사, 심근 SPECT, 심도자 및 조영술상 수술 직후와 비교해서 좌심박출계수, 좌심실 확장기말용적, 좌심실 수축기말용적은 큰 차이는 없었으나, 좌심실 용적들은 조금씩 늘어나는 양상을 보였다. 결론: 허혈성심근질환에서 좌심실내 패취 성형술은 현저하게 좌심박출계수의 향상과 좌심실용적의 감소를 가져오며 술 후 1년까지도 지속되었으나, 좌심실용적은 다소 증가하는 양상을 보여 술 후에도 좌심실의 재확장을 막기 위한 적극적인 약물치료가 필요함을 시사하였다.

We evaluated the efficacy of Dor procedure in patients with ischemic left ventricular dysfunction. Material and Method: Between April 1998 and December 2002, 45 patients underwent the Dor procedure con-comitant with coronary artery bypass grafting (CABG). Left ventricular ejection fraction (LVEF) and left ventricular end-diastolic/end-systolic volumes (LVEDV/LVESV) were measured by echocardiography, myocardial SPECT, and cardiac catheterization and angiography performed at the sequence of preoperative, early postoperative, and one year postoperative stage. Result: Cardiopulmonary bypass and aortic clamp times were mean 141$\pm$64, 69$\pm$24 minutes, respectively. Intraaortic balloon pump (IABP) therapy was required in 19 patients (42%; 7 preoperatively, 9 intraoperatively, 3 postoperatively). Operative mortality rate was 2.2% (1/45). Postoperative morbidities were low cardiac output syndrome (12), atrial fibrillation (5), acute renal failure (4), and postoperative bleeding (4). Functional class (NYHA) was improved from classes 2.8 to 1.1 (p < 0,01). When we compared between the preoperative and early postoperative values, LVEF was improved from 32$\pm$9% to 52$\pm$11% (p<0.01). The asynergy portion decreased from 57$\pm$12% to 22$\pm$9%, and LVEDV/LVESV indexes improved from 125$\pm$39 mL/$m^2$, 85$\pm$30 mL/$m^2$ to 66$\pm$23 mL/$m^2$, 32$\pm$16 mL/$m^2$ (p<0.01). Although these changes in volumes were relatively preserved at postoperative one year, the left ventricular volumes showed a tendency to increase. Conclusion: After the Dor procedure for ischemic left ventricular dysfunction, LVEF improvement and left ventricular volume reduction were maintained till postoperative one year. The tendency for left ventricular volume to increase at postoperative one year suggested the requirement of strict medical management.

키워드

참고문헌

  1. Ann Thorac Surg v.75 no.SUP. 6 Ventricular reconstruction for ischemic cardiomyopathy Mickleborough LL;Merchant N;Provost Y(et al.)
  2. Am Heart J v.134 A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) Califf RM;Adams KF;McKenna WJ(et al.)
  3. Circulation v.91 Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction Greenberg B;Quinones MA;Koilpillai C(et al.)
  4. BMJ v.320 ABC of heart failure: clinical features and complications Waston RDS;Gibbs CR;Lip GY
  5. Circulation v.74 Advantages and applications of the centerline method for characterizing regional ventricular function Sheehan FH;Bolson EL;Dodge HT(et al.)
  6. Circulation v.67 Indications for left ventricular aneurysmectomy Cohen M;Packer M;Gorlin R
  7. J Thorac Cardiovasc Surg v.37 Left ventricular aneurysm: a new surgical approach Dor V;Saab M Coste P;Kornaszewska M;Montiglio F
  8. J Thorac Cardiovasc Surg v.124 Basic science review: The helix and the heart Buckberg GD
  9. J Thorac Cardiovasc Surg v.121 Effects of the Dorprocedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery Di Donato M;Sabatier M;Dor V(et al.)
  10. 2001 AATS 81st Annual Meeting Rationale behind new non-transplant surgical approaches to advanced LV dysfunction and CHF Buckberg G
  11. J Thorac Cardiovasc Surg v.119 Nontransplant cardiac surgery for end-stage cardiomyopathy Suma H;Isomura T;Horii T(et al.)
  12. Eur J Cardiothorac Surg v.14 Ventricular remodelling and revascularization in severe left ventricular dysfunction Pathi VL;Pillay TM;Lall K(et al.)
  13. Eur J Cardiothorac Surg v.20 Left ventriculo-plasty for ischemic cardiomyopathy Suma H;Isomura T;Horii T;Hisatomi K(et al.)
  14. J Am Coll Cardiol v.36 Results of partial left ventriculectomy for dilated cardiomyopathy Starling R;McCarthy P;Buda T(et al.)
  15. Jpn J Thorac Cardiovasc Surg v.52 Efficacy of endoventricular circular patch plasty: will this procedure improve the prognosis of patients with ischemic cardiomyopathy? Kokaji K;Okamoto M;Hotoda K;Maehara T;Kumamaru H;Koizumi K
  16. Ann Thorac Surg v.75 Ventricular energetics in endoventricular circular patch plasty for dyskinetic anterior left ventricular aneurysm Tanoue Y;Ando H;Fukumura F(et al.)
  17. Eur J Cardiothorac Surg v.23 Left ventricular restoration for ischemic cardiomyopathy-comparison of presence and absence of mitral valve procedure Isomura T;Suma H;Yamaguchi A(et al.)
  18. Circulation v.108 no.Ⅱ Importance of mitral valve repair associated with left ventricular reconstruction for patients with ischemic cardiomyopathy: A real-time three-dimensional echocardiographic study Qin JX;Shiota T;McCarthy PM(et al.)
  19. Circulation v.106 no.Ⅰ Combined procedure of surgical repair and cell transplantation for left ventricular aneurysm: An experimental study Sakakibara Y;Tambara K;Lu F(et al.)
  20. Circulation v.108 no.Ⅱ Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts Matsubayashi K;Fedak PWM;Mickle DAG(et al.)